| Amber M Clay, LPC | |
|
174 Lmah Center Rd, Logan, WV 25601-4058 | |
| (304) 792-7130 | |
| (304) 896-5184 |
| Full Name | Amber M Clay |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 174 Lmah Center Rd, Logan, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093481087 | NPI | - | NPPES |
| 2621 | Other | WV | WV BOARD OF COUNSELING |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 2621 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amber M Clay, LPC Po Box 176, Logan, WV 25601-0176 Ph: (304) 792-7130 | Amber M Clay, LPC 174 Lmah Center Rd, Logan, WV 25601-4058 Ph: (304) 792-7130 |
News Archive
Researchers at the University of Toronto specializing in language variation and change have identified a specific relationship between an individual's use of language, and the transition from healthy to a diagnosis of severe dementia.
The Oslo-Axess-listed Norwegian biopharmaceutical company PCI Biotech Holding ASA today announced that it has raised NOK90 million through a new rights issue. The company received subscriptions for a total of approximately 3.36 million new shares. The initial offering was and remains 2,250,000 new shares, and the rights issue was thus oversubscribed by approximately 50 percent.
ChromaDex Corporation, a leader in phytochemical reference standards and contract research, today announced financial results for the third quarter of 2009. On a reported basis calculated in accordance with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ChromaDex announced a net loss attributable to common stockholders of $0.01 per share for the thirteen week period ended October 3, 2009.
Mylan Inc. today announced that its subsidiary, Mylan Pharmaceuticals Inc., has filed suit against the U.S. Food and Drug Administration (FDA) in the U.S. District Court for the District of Columbia seeking to overturn a decision by FDA, which awarded Teva sole 180-day exclusivity for the generic version of its affiliate Cephalon's Provigil.
› Verified 9 days ago
Bradley Barnett, Counselor Medicare: Not Enrolled in Medicare Practice Location: 312 Hudgins St, Logan, WV 25601 Phone: 304-896-5001 | |
Rachel Ball, M.ED., NCC., LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 313 Hudgins St, Logan, WV 25601 Phone: 304-752-7830 Fax: 304-752-7832 | |
Wendi Leann Watts, M.ED. COUNSELING Counselor Medicare: Not Enrolled in Medicare Practice Location: 313 Hudgins St, Logan, WV 25601 Phone: 304-752-7830 | |
Brandon Scott Bailey, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Logan, WV 25601 Phone: 304-896-5001 | |
Mrs. Sandra Bernadine Vance, M.ED., LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 174 Lmamh Center Road, Logan, WV 25601 Phone: 304-792-7130 Fax: 304-792-7146 | |
Ronni Beth Vance, M.ED , NCC,LPC #2578 Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Dingess St, Logan, WV 25601 Phone: 304-688-9269 |